Then, we postulated that the increase in PD1+ CD57+ CD8+ TEMRA cells in patients with MCI-AD might be a component of a recent immune response, which could be reflected by associations between CD8+ TEMRA cells and other immune cell subsets in the early stages of the disease. This evidence concerns the gene PDCD1 and Alzheimer disease.